We are pleased to share the recording of our recent webinar, “News from ASH 2024”, where we explored the latest advancements in myeloproliferative neoplasm (MPN) research presented at the American Society of Hematology (ASH) 2024 Annual Meeting.

Leading MPN expert Dr. Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, provided a comprehensive overview of key ASH 2024 findings, including:

• Emerging treatments and clinical trials in MPNs
• Advances in understanding disease progression
• Insights into patient-centered care and future research directions

Watch the Webinar Recording

This webinar is a valuable resource for patients, caregivers, and advocates seeking to stay informed about the latest developments in MPN treatment and research.